Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researcher Looks to the Oceans for Bioactive Natural Products as Chemo-preventatives for Pancreatic Cancer

09.07.2009
Reseachers are looking to the oceans as a rich source of bioactive natural products that inhibit inflammation as potential novel chemo-preventatives of pancreatic cancer. The uniqueness, chemical diversity and complexity of marine natural products represent an unexploited supply of potential new drugs, lead compounds for medicinal chemistry and biological probes to allow for a better understanding of diseases, including pancreatic cancer.

Dr. Esther Guzm¨¢n, assistant research professor at Harbor Branch Oceanographic Institute at Florida Atlantic University, has received a $375,000 grant from the Bankhead Coley Florida Biomedical Research Program for a research project to identify bioactive marine natural products that inhibit inflammation as potential novel chemo-preventatives of pancreatic cancer.

Pancreatic cancer is the fifth most lethal cancer in the United States due to its strong metastatic potential and its delayed detection, as most patients remain asymptomatic until the cancer metastasizes. Ninety-five percent of patients diagnosed with the disease die within five years of diagnosis.

Guzm¨¢n, an expert in immunology and cancer research, and her colleagues are looking to the oceans as a rich source of bioactive natural products. The uniqueness, chemical diversity and complexity of marine natural products represent an unexploited supply of potential new drugs, lead compounds for medicinal chemistry and biological probes to allow for a better understanding of diseases including pancreatic cancer.

¡°Esther exemplifies excellence as a young scientist at Harbor Branch,¡± said Dr. Amy Wright, professor and director of the Center for Marine Biomedical and Biotechnology Research at Harbor Branch, where Guzm¨¢n works. ¡°Receiving this highly competitive award is further evidence of the value of her cutting-edge research and her many skills and talents.¡±

The Center for Marine Biomedical and Biotechnology Research at Harbor Branch has developed a unique screening library of secondary metabolites isolated from deep water marine invertebrates that hold promise in preventing both the formation of new pancreatic tumors and the metastasis of existing tumors which are facilitated by chronic inflammation. Guzm¨¢n will utilize this library to identify novel inhibitors of inflammation expected to be found among secondary metabolites from marine organisms. Three important signaling molecules in inflammation have been validated as chemo-preventative drug targets in pancreatic cancer: the nuclear factor ¦ÊB (NF¦ÊB), interleukin 8 (IL-8/CXCL8) and the signal transducer and activator of transcription 3 (STAT3). These researchers will focus on these molecules, which are important inflammatory regulators and have been implicated with the aggressiveness of pancreatic cancer. Once they have confirmed the activity in pancreatic cancer cells, the most active samples will be further validated by determining if they help stop the proliferation of pancreatic cancer cells or promote their death. The data obtained from this project will be used to secure funding to perform the steps necessary to bring compounds discovered through this research closer to the patient.

According to an article titled ¡°Inflammation and the Development of Pancreatic Cancer¡± published in the Journal of Surgical Oncology (Farrow, B. and B.M. Evers ¨C 2002), chronic pancreatitis is a progressive, destructive inflammatory process that ends in total destruction of the pancreas. Patients who suffer from hereditary pancreatitis have a 53 times higher risk of developing pancreatic cancer than unaffected individuals; patients with sporadic chronic pancreatitis have a 17 times higher risk.

¡°While the exact reason why pancreatitis patients have an increased risk of developing pancreatic cancer is not understood, inflammation is thought to create a microenvironment that facilitates the initiation and/or growth of pancreatic cancer cells,¡± said Guzm¨¢n.

Every seventeen minutes someone is diagnosed with pancreatic cancer. According to the American Cancer Society, the risk of developing pancreatic cancer increases with age. Almost 90% of patients are older than 55 and the average age at the time the cancer is found is 72.

¡°Current treatments for pancreatic cancer remain only moderately effective, as attested by the low survival rate,¡± said Guzm¨¢n. ¡°Furthermore, this type of cancer is highly resistant to all current chemotherapies, and novel drugs and new therapies are urgently needed to treat this disease.¡±

Harbor Branch Oceanographic Institute at Florida Atlantic University is a research institute dedicated to exploration, innovation, conservation, and education related to the oceans. Harbor Branch was founded in 1971 as a private non-profit organization. In December 2007, Harbor Branch joined Florida Atlantic University. The institute specializes in ocean engineering, at-sea operations, drug discovery and biotechnology from the oceans, coastal ecology and conservation, marine mammal research and conservation, aquaculture, and marine education. For more information, visit www.hboi.fau.edu.

Florida Atlantic University opened its doors in 1964 as the fifth public university in Florida. Today, the University serves more than 26,000 undergraduate and graduate students on seven campuses strategically located along 150 miles of Florida's southeastern coastline. Building on its rich tradition as a teaching university, with a world-class faculty, FAU hosts ten colleges: College of Architecture, Urban & Public Affairs, Dorothy F. Schmidt College of Arts & Letters, the Charles E. Schmidt College of Biomedical Science, the Barry Kaye College of Business, the College of Education, the College of Engineering & Computer Science, the Harriet L. Wilkes Honors College, the Graduate College, the Christine E. Lynn College of Nursing and the Charles E. Schmidt College of Science.

Gisele Galoustian | Newswise Science News
Further information:
http://www.fau.edu

More articles from Life Sciences:

nachricht Symbiotic bacteria: from hitchhiker to beetle bodyguard
28.04.2017 | Johannes Gutenberg-Universität Mainz

nachricht Nose2Brain – Better Therapy for Multiple Sclerosis
28.04.2017 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>